Quarterly Report for Quarter Ending March 31, 2025 (Form 10-Q)
-3d
Prelude Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update
-3d
Additional Proxy Soliciting Materials (Form DEFA14A)
4/29
Proxy Statement (Form DEF 14A)
4/29
PRLD Conference Call Slide Deck FINAL 9122024
4/14
Preliminary Proxy Statement (Form PRE 14A)
4/11
Statement of Changes in Beneficial Ownership (Form 4)
4/7
Failure to Satisfy Listing Rule (Form 8-K)
3/28
Statement of Changes in Beneficial Ownership (Form 4)
3/27
Statement of Changes in Beneficial Ownership (Form 4)
3/27